CORRESP Filing
Erasca, Inc.
Date: Aug. 20, 2025 · CIK: 0001761918 · Accession: 0001193125-25-184070
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-289537
Letter
Re: Erasca, Inc. Registration Statement on Form S-3 File No. 333-289537 To the addressees set forth above: Pursuant to Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, on behalf of Erasca, Inc., respectfully requests that the effective date of the Registration Statement on Form S-3 referred to above be accelerated so that it will become effective at 4:00 P.M. Eastern Time on August 22, 2025, or as soon as practicable thereafter. If you have any questions or require additional information, please contact Matthew T. Bush, Esq. of Latham & Watkins LLP at (858) 523-3962. Thank you for your assistance and cooperation in this matter.
Erasca, Inc. 3115 Merryfield Row, Suite 300 San Diego, CA 92121 August 20, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549
Very truly yours,
ERASCA, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Erasca, Inc. 3115 Merryfield Row, Suite 300 San Diego, CA 92121 August 20, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Re: Erasca, Inc. Registration Statement on Form S-3 File No. 333-289537 To the addressees set forth above: Pursuant to Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, on behalf of Erasca, Inc., respectfully requests that the effective date of the Registration Statement on Form S-3 referred to above be accelerated so that it will become effective at 4:00 P.M. Eastern Time on August 22, 2025, or as soon as practicable thereafter. If you have any questions or require additional information, please contact Matthew T. Bush, Esq. of Latham & Watkins LLP at (858) 523-3962. Thank you for your assistance and cooperation in this matter. Very truly yours, ERASCA, INC. By: /s/ Jonathan E. Lim Jonathan E. Lim, M.D. Chairman, Chief Executive Officer and Co-Founder cc: Ebun S. Garner, Erasca, Inc. Cheston J. Larson, Latham & Watkins LLP Matthew T. Bush, Latham & Watkins LLP